OIG audit in Guinea-Bissau questions whether PBF is possible where performance data are not reliable
The Office of the Inspector General (OIG) says that its recent audit of grants to Guinea-Bissau raises questions about the suitability of performance-based funding in countries where performance data are not reliable.
“The expectations for reporting, management and oversight placed on fragile states by the Global Fund have not been realistic,” the OIG said.
The Office of the Inspector General (OIG) has released five new reports – three on audits in Bangladesh, Djibouti and Ghana, and two on investigations in Djibouti and South Africa. All five reports are dated 29 October 2012.
The Coca-Cola Company and the Global Fund are expanding a project which uses Coca-Cola’s distribution systems and business expertise to help government and non-governmental organisations deliver critical medicines to remote parts of Africa, according to a news
According to data compiled by the Global Fund, since the introduction of the Affordable Medicines Facility-malaria (AMFm) programme, the average cost of a course of artemisinin combination therapy (ACT) in private pharmacies has dropped by about 90% in parts of Kenya and by about 40% to 90% in Ghana, the first two countries to participate in the programme.